GlucoTrack, Inc. (NASDAQ:GCTK) Short Interest Update
by Jessica Moore · The Cerbat GemGlucoTrack, Inc. (NASDAQ:GCTK – Get Free Report) saw a significant decrease in short interest in the month of November. As of November 30th, there was short interest totalling 85,700 shares, a decrease of 66.7% from the November 15th total of 257,700 shares. Approximately 1.1% of the shares of the company are sold short. Based on an average daily volume of 391,800 shares, the short-interest ratio is presently 0.2 days.
GlucoTrack Stock Performance
NASDAQ:GCTK traded down $0.01 during trading hours on Wednesday, reaching $0.28. The company had a trading volume of 1,282,420 shares, compared to its average volume of 132,441. The firm has a market cap of $1.62 million, a price-to-earnings ratio of -0.10 and a beta of -0.16. The company has a current ratio of 0.14, a quick ratio of 0.14 and a debt-to-equity ratio of 0.52. The firm’s 50 day moving average price is $1.24 and its 200-day moving average price is $1.80. GlucoTrack has a 52 week low of $0.22 and a 52 week high of $4.95.
GlucoTrack Company Profile
GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.
Read More
- Five stocks we like better than GlucoTrack
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- The Great CPU Race: AMD and Intel Battle for Dominance
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- Where to Find Earnings Call Transcripts
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns